Results
1 -
10 of
46
(Click
here to explore results)
- A polymeric IDO inhibitor based on poly(ethylene glycol)-b-poly(l-tyrosine-co-1-methyl-d-tryptophan) enables facile trident cancer immunotherapy. Yuanyuan Liu, Jiguo Xie, Xiaofei Zhao, Yueyue Zhang, Zhiyuan Zhong, Chao Deng
, Biomater. Sci.
, 2022
, 10
, 5731
- Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Xiu-Xiu Wang, Si-Yu Sun, Qing-Qing Dong, Xiao-Xiang Wu, Wei Tang, Ya-Qun Xing
, Med. Chem. Commun.
, 2019
, 10
, 1740
- A dual-responsive doxorubicin–indoximod conjugate for programmed chemoimmunotherapy. Zhaoxuan Yang, Jiaqi Huang, Yaying Lin, Xiangjie Luo, Haojin Lin, Hongyu Lin, Jinhao Gao
, RSC Chem. Biol.
, 2022
, 3
, 853
- Bioengineered nanogels for cancer immunotherapy. Xianbin Ma, Shu-Jin Li, Yuantong Liu, Tian Zhang, Peng Xue, Yuejun Kang, Zhi-Jun Sun, Zhigang Xu
, Chem. Soc. Rev.
, 2022
, 51
, 5136
- Surgery-free injectable macroscale biomaterials for local cancer immunotherapy. Kewen Lei, Li Tang
, Biomater. Sci.
, 2019
, 7
, 733
- Molecular and nanoengineering approaches towards activatable cancer immunotherapy. Chi Zhang, Kanyi Pu
, Chem. Soc. Rev.
, 2020
, 49
, 4234
- Eliciting an immune hot tumor niche with biomimetic drug-based multi-functional nanohybrids augments immune checkpoint blockade-based breast cancer therapy. Wei Du, Chen Chen, Peng Sun, Shengchang Zhang, Jing Zhang, Xiaoyu Zhang, Ying Liu, Rui Zhang, Chongzheng Yan, Changchun Fan, Jibiao Wu, Xinyi Jiang
, Nanoscale
, 2020
, 12
, 3317
- Thioether-based ROS responsive polymers for biomedical applications. Miryam Criado-Gonzalez, David Mecerreyes
, J. Mater. Chem. B
, 2022
, 10
, 7206
- Measurement of methylated metabolites using liquid chromatography-mass spectrometry and its biological application. Chandrashekar R. Ambati, Venkatrao Vantaku, Sri Ramya Donepudi, Chandra Sekhar Amara, Shiva Shankar Ravi, Akhil Mandalapu, Maharajni Perla, Vasanta Putluri, Arun Sreekumar, Nagireddy Putluri
, Anal. Methods
, 2019
, 11
, 49
- Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer. Xinlong Zang, Jinxiao Song, Xie Yi, Jiang Piyu
, J. Mater. Chem. B
, 2022
, 10
, 2019